For over 50 years, the Livengrin Foundation has stood as a beacon of hope for families across the Philadelphia and New Jersey regions. We’ve navigated the waves of the heroin epidemic, the rise of synthetic fentanyl, and the recent, devastating arrival of xylazine (often called “Tranq”). Our mission has always been to provide compassionate, expert care that meets patients exactly where they are.
However, the landscape of addiction is shifting once again. If you live in the Philly metro area or South Jersey, you may have recently heard a new, frightening word: Medetomidine.
Just as the community began to understand the risks of xylazine, this even more potent substance has entered the local drug supply. At Livengrin, we believe that knowledge is a vital tool for families in crisis. When you understand the specific threats your loved one is facing, you can better advocate for their safety and find the right addiction treatment centers to help them heal.
Here are 10 crucial things Philadelphia and New Jersey families need to know about medetomidine.
1. It is a Veterinary Sedative, Not an Opioid
Like xylazine before it, medetomidine was never intended for human consumption. It is an alpha-2 agonist: a powerful sedative used by veterinarians to tranquilize large animals. Because it is not an opioid, it does not respond to naloxone (Narcan) in the way fentanyl does. While it is almost always mixed with opioids in the street supply, the sedative effect itself is a separate pharmacological challenge that requires specialized medical management.
2. It is Significantly More Potent Than “Tranq”
One of the most alarming aspects of medetomidine is its strength. Experts suggest it is anywhere from 100 to 200 times more potent than xylazine. This means that even a microscopic amount can cause profound, life-threatening sedation. For families who have already witnessed the heavy “nod” associated with xylazine, medetomidine represents an even deeper level of unconsciousness that is much harder to wake someone from.
3. Philadelphia is the Epicenter of This New Wave
While new drugs often appear in different parts of the country simultaneously, medetomidine was first detected in the Philadelphia drug supply in May 2024. Since then, its presence has exploded. Be-cause of our proximity to Kensington and the major transit hubs connecting Philly to Camden, Tren-ton, and the Jersey Shore, families in our region are often the first to encounter these emerging threats. If you are searching for Philadelphia rehab centers, it is vital to choose one that stays updated on these local trends.
4. It is Rapidly Replacing Xylazine
The drug supply is constantly evolving based on availability and cost for manufacturers. In mid-2024, testing of drug samples in Philadelphia showed a massive shift: medetomidine presence jumped from 29% to over 80% in a matter of months, while xylazine levels began to drop. For your loved one, this means the “dope” they were using yesterday may be drastically different and much more dangerous today, even if it looks and smells the same.
5. It Causes Dangerous Drops in Heart Rate and Blood Pressure
The medical complications of medetomidine are severe. Because it is a powerful sedative, it slows the body’s vital functions to a crawl. We are seeing individuals with heart rates dropping into the 20s (a normal resting heart rate is 60–100). This can lead to fainting, cardiac arrest, and long-term damage to vital organs. This is why a medically supervised admissions process is so important: detoxing from these substances at home is incredibly risky.
6. Withdrawal Symptoms Are Intense and Unique
When medetomidine is mixed with fentanyl, the individual experiences two different types of withdrawal at once. In addition to the standard opioid withdrawal (aches, fever, cravings), medetomidine withdrawal brings severe tremors, “intractable” nausea, and extreme anxiety. At Livengrin, we focus on a personalized approach to manage these complex symptoms, ensuring dignity and comfort during the most difficult early days of recovery.
7. It is Never Sold Alone
Medetomidine is an “adulterant,” meaning it is used to “cut” or stretch the supply of fentanyl. You won’t find someone looking to buy “just” medetomidine. It is always hidden within the opioid supply to mimic or extend the high of the fentanyl. This makes every dose a game of Russian roulette, as the user has no way of knowing the ratio of sedative to opioid they are injecting or snorting.
8. Testing Strips Are Now Available
There is a small glimmer of hope for harm reduction: medetomidine test strips do exist. Similar to fentanyl test strips, these allow individuals or family support networks to check for the presence of the drug. While the goal is always total abstinence and recovery, keeping someone alive long enough to reach that goal is the first priority.
9. Overdose Response Requires a Different Strategy
Because medetomidine doesn’t respond to Narcan, a person may remain unconscious even after you’ve administered multiple doses of the reversal agent. The priority must be rescue breathing. If the fentanyl is blocked by Narcan but the medetomidine is still sedating the brain, the person may not wake up, but they must keep breathing. Call 911 immediately and stay with the individual until help arrives.
10. It Goes by Street Names Like “Rhino Tranq”
In the Philadelphia and New Jersey areas, you might hear this combination referred to as “Rhino Tranq” or “Flysky.” These names often glamorize the potency, but the reality is a state of deep, dangerous “zombie-like” sedation that leaves the individual vulnerable to theft, assault, and environmental exposure.
Why Local Expertise Matters
Navigating the world of addiction is overwhelming, especially when the “rules” seem to change every few months. Families in Bucks County, Montgomery County, and across the bridge in Jersey shouldn’t have to become toxicologists to save their loved ones.
At Livengrin, our staff of highly qualified clinicians and medical professionals are constantly monitoring these trends. We understand that “no two paths look the same,” and a person struggling with a medetomidine-laced fentanyl habit needs a different clinical approach than someone struggling with alcohol. We meet patients where they are: whether that is through our intervention services to help a family start the conversation, or our workforce program for professionals whose careers are on the line.
A Message of Hope
While the news of medetomidine is heavy, it does not mean recovery is impossible. Every day at Livengrin, we see individuals who have survived the worst of the Philadelphia drug crisis find their way back to health, family, and purpose.
Recovery is a journey that requires a compassionate community. We provide that community through our alumni meetings and ongoing support networks. You are not alone in this fight.
If you suspect your loved one is using substances that may be adulterated with medetomidine or xylazine, don’t wait for a crisis to happen. Reach out to us to learn about what to expect during treatment and how we can help your family find peace again.
Take the first step today:
- Visit our Admissions Page
- Explore our Outpatient Services
- Call us directly to speak with a compassionate professional who understands the unique challenges of the Philly/NJ region.
Recovery is possible, and it starts with a single, courageous phone call. Let us be your partner in this journey.